Comments

AstraZeneca Stock Guidance

AZNNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$73.05
-1.04-1.40%
At close: -
$72.60
-0.45-0.61%
After Hours: 4:58 PM EDT
AstraZeneca (AZN) ForecastNewsEarningsAstraZeneca (AZN) Options

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

AstraZeneca Stock Guidance | NASDAQ:AZN | Benzinga

AstraZeneca issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/12/2021AZN
AstraZeneca
FY2021$2.52$2.70$3.27———Get Alert
07/29/2021AZN
AstraZeneca
FY2021$2.52$2.70$3.33———Get Alert
04/30/2021AZN
AstraZeneca
FY2021$2.38$2.50$2.11———Get Alert
02/11/2021AZN
AstraZeneca
FY2021$2.38$2.50$2.95———Get Alert

FAQ

Q

What is the most recent guidance for AstraZeneca (AZN)?

A

The most recent guidance for AstraZeneca (AZN) was reported on November 12, 2021 for the full year 2021. The company provided earnings per share guidance in the range of $2.53 to $2.70, compared to the estimated EPS of $3.27. Additionally, AstraZeneca forecasted revenue between $0.00B and $0.00B for the quarter.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved